APPF vs REGN · P/E 43, rev $794.2M vs P/E 14, rev $14.34B
Appfolio Inc (APPF) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Appfolio Inc (APPF) is a software - application company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported APPF revenue for 2024-12-31 was $794.2M. Net income was $204.1M. Revenue was up 28.0% from 2023-12-31 to 2024-12-31. APPF currently screens at market cap $8.38B and trailing P/E 43.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
APPF currently screens at market cap $8.38B and trailing P/E 43.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the APPF and REGN stock pages for the full models.
Not investment advice.